Walburn T, Chen MH, Loffredo M, McMahon E, et al. Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable-risk prostate cancer patients receiving docetaxel: Insights from a randomized trial. Cancer 2024 Mar 1. doi: 10.1002/cncr.35274.
PMID: 38427287